Delivery Order SPE2DB22D3016-SPE2DB25FBGR5
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,746.56 for Suprane Inhalation Liquid (240ml) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,076.30 for 240mL of Suprane inhalation liquid, with an ultimate completion date of August 20, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded on August 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order falls under...
- The Defense Logistics Agency awarded a $5,379.52 delivery order to AmerisourceBergen Drug Corp for Suprane Inhalation Liquid 240ML, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The work will be performed at AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Suprane Inhalation Liquid 240ML, a pharmaceutical product, with a ceiling value of $5,187.00 and a period of performance through June 27, 2025. The award is not set aside and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $6,131.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Suprane Inhalation Liquid 240ML. The contract has a firm fixed price and is set to expire on December 24, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $1,867.32 for AirSupra 90-80 microgram inhalant in 10.7-gram units. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded, and carries an ultimate completion date of September 30, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,762.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Airsupra 90-80 microgram inhaler (10.7 grams) on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside competitive award is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,376.37 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical product. This competitively awarded, firm fixed price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,696.72 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This firm fixed-price, non-set-aside delivery order was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,734.64 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhalator (10.7gm) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded contract with firm fixed pricing carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGR5Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,741.84 on August 28, 2025, for the supply of Suprane Inhalation Liquid in 240ml quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 29, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle extending through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for anesthetic inhalation liquid reflects the company's role as a prime vendor within DLA's Medical Supply Chain, fulfilling specialized pharmaceutical needs essential to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/28/25 |